Lastest Insider Transactions Of Aquestive Therapeutics, Inc. ( AQST )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-11-30Option Exercise14,5720.0002019-12-02 16:56:31
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-11-30Option Exercise14,5720.0002019-12-02 16:56:03
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-09-30Option Exercise3290.0002019-10-02 16:33:51
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-09-30Option Exercise3290.0002019-10-02 16:33:19
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-08-31Option Exercise14,5720.0002019-09-03 18:09:22
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-08-31Option Exercise14,5720.0002019-09-03 18:09:06
AQSTAquestive Therapeutics, Inc.Barber DanielSVP-Chief Operating Officer2019-08-27Buy2,0003.997,9802019-08-27 21:49:13
AQSTAquestive Therapeutics, Inc.Scibetta James SDirectior2019-08-19Buy22,9713.7986,9772019-08-22 16:30:15
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-08-09Buy8,0003.8730,9872019-08-20 16:30:12
AQSTAquestive Therapeutics, Inc.Wood TheresaSVP-HR and Org. Development2019-08-09Buy1,0003.993,9902019-08-13 16:30:17
AQSTAquestive Therapeutics, Inc.BRAENDER LORI JSVP, General Counsel2019-08-09Buy10,0004.0740,7472019-08-13 16:30:14
AQSTAquestive Therapeutics, Inc.Boyd Peter E.SVP-Bus. Process & Info. Tech.2019-08-12Buy6003.812,2862019-08-13 16:30:12
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-06-30Option Exercise3290.0002019-07-02 16:30:15
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-06-30Option Exercise3290.0002019-07-02 16:30:12
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-05-31Option Exercise14,5720.0002019-06-03 16:15:16
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-05-31Option Exercise14,5720.0002019-06-03 16:15:12
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-03-31Option Exercise3290.0002019-04-01 16:40:57
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-03-31Option Exercise3290.0002019-04-01 16:40:23
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2019-02-28Option Exercise14,5720.0002019-03-01 17:24:11
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2019-02-28Option Exercise14,5720.0002019-03-01 17:23:55
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-12-31Option Exercise3290.0002019-01-03 17:30:00
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-12-31Option Exercise3290.0002019-01-03 17:23:36
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-12-10Buy1,0007.787,7802018-12-11 17:41:13
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-12-06Buy2,0008.6917,3802018-12-10 17:47:07
AQSTAquestive Therapeutics, Inc.Barber DanielSVP-Chief Strategy/Dev Officer2018-12-10Buy1,0008.008,0002018-12-10 17:46:20
AQSTAquestive Therapeutics, Inc.Maxwell John T.SVP-Chief Financial Officer2018-12-06Buy5,0008.8744,3502018-12-07 16:27:58
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-11-30Option Exercise14,5720.0002018-12-04 16:05:07
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-11-30Option Exercise14,5720.0002018-12-04 16:02:51
AQSTAquestive Therapeutics, Inc.Marshall Ken W.Commercial Leader2018-11-21Buy1,44510.1514,6672018-12-03 16:01:29
AQSTAquestive Therapeutics, Inc.BRAENDER LORI JGeneral Counsel2018-11-27Buy1,00010.5710,5702018-11-29 16:01:45
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-11-27Buy1,0009.879,8702018-11-28 16:01:31
AQSTAquestive Therapeutics, Inc.Wood TheresaSVP-HR and Org. Development2018-11-26Buy50010.345,1702018-11-26 14:53:20
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-11-21Buy1,00010.2510,2502018-11-26 13:43:06
AQSTAquestive Therapeutics, Inc.Maxwell John T.SVP-Chief Financial Officer2018-11-21Buy10,0009.8098,0002018-11-26 13:39:56
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-11-21Buy7,95010.1080,3252018-11-26 13:38:01
AQSTAquestive Therapeutics, Inc.Boyd Peter E.SVP-Operations/Value Delivery2018-11-21Buy2009.981,9962018-11-26 13:35:15
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-09-30Option Exercise3290.0002018-10-02 16:38:53
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-09-30Option Exercise3290.0002018-10-02 16:37:04
AQSTAquestive Therapeutics, Inc.Kendall Keith JCEO and President2018-08-31Option Exercise14,5720.0002018-09-05 17:41:54
AQSTAquestive Therapeutics, Inc.Schobel Alexander MarkChief Innovation/Tech Officer2018-08-31Option Exercise14,5720.0002018-09-05 17:39:56
AQSTAquestive Therapeutics, Inc.BRATTON DOUGLAS KDirectior 10% Owner2018-07-24Buy165,00015.002,475,0002018-07-26 14:59:47